Brett Guthrie said...
The adequacy of FDA's oversight of the U.S. drug supply has been a longstanding issue for this committee.
Context
Guthrie highlights ongoing concerns about FDA's drug supply oversight.
12/09/2019
Guthrie highlights ongoing concerns about FDA's drug supply oversight.
12/09/2019